Corporate Overview

Milagen is a private diagnostic company. Since 1997, Milagen has been engaged in the discovery and development of non-invasive, easy-to-use immunodiagnostic products for the surveillance, monitoring and detection of major cancers with unmet needs.

Milagen has discovered and thoroughly validated proprietary biomarkers expressed in major cancers (i.e. breast, colon, lung, ovarian, prostate, pancreatic). The Company is developing a new generation of tissue and serum-based diagnostic products for cancer surveillance and monitoring.